Ji-Min Cao Selected Research

zacopride

1/2021	Cardioprotection of an IK1 channel agonist on L-thyroxine induced rat ventricular remodeling.
1/2019	IK1 Channel Agonist Zacopride Alleviates Cardiac Hypertrophy and Failure via Alterations in Calcium Dyshomeostasis and Electrical Remodeling in Rats.
1/2017	The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.
10/2014	Activation of IK1 channel by zacopride attenuates left ventricular remodeling in rats with myocardial infarction.
10/2014	On the risk concerns of zacopride, a moderate IK1 channel agonist with cardiac protective action.
1/2012	A novel discovery of IK1 channel agonist: zacopride selectively enhances IK1 current and suppresses triggered arrhythmias in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ji-Min Cao Research Topics

Disease

6	Ventricular Tachycardia 01/2017 - 01/2002
5	Neoplasms (Cancer) 01/2022 - 09/2014
5	Ventricular Fibrillation 01/2017 - 01/2002
4	Bradycardia 01/2020 - 04/2013
4	Tachycardia (Tachyarrhythmias) 01/2020 - 03/2013
4	Myocardial Infarction 01/2017 - 01/2002
4	Cardiac Arrhythmias (Arrythmia) 12/2016 - 01/2002
4	Inflammation (Inflammations) 12/2015 - 11/2010
4	Ovarian Neoplasms (Ovarian Cancer) 10/2014 - 12/2013
4	Atrioventricular Block 01/2014 - 01/2002
3	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2019
3	Atherosclerosis 11/2019 - 04/2007
3	Heart Failure 01/2019 - 03/2004
3	Hypertrophy 01/2019 - 09/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2006
3	Heart Arrest (Cardiac Arrest) 08/2017 - 03/2013
3	Ischemia 01/2017 - 10/2005
3	Breast Neoplasms (Breast Cancer) 03/2014 - 01/2014
2	Ventricular Remodeling 01/2021 - 10/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 07/2017
2	Atherosclerotic Plaque (Atheroma) 11/2019 - 04/2010
2	Neointima 11/2019 - 04/2010
2	Atrial Remodeling 01/2019 - 01/2002
2	Fibrosis (Cirrhosis) 01/2019 - 09/2012
2	Pheochromocytoma 01/2019 - 07/2009
2	Heart Diseases (Heart Disease) 08/2018 - 10/2008
2	Hypoxia (Hypoxemia) 01/2017 - 12/2013
2	Lymphatic Metastasis 03/2014 - 02/2014
2	Type 2 Diabetes Mellitus (MODY) 12/2013 - 04/2012
2	Insulin Resistance 12/2013 - 11/2010
2	Obesity 12/2013 - 11/2011
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2006 - 10/2005
1	Body Weight (Weight, Body) 08/2022
1	Infections 04/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2019

Drug/Important Bio-Agent (IBA)

6	zacoprideIBA 01/2021 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2008
4	PotassiumIBA 01/2021 - 10/2008
4	Nerve Growth Factor (NGF)IBA 01/2019 - 01/2002
3	Lysine (L-Lysine)FDA Link 01/2022 - 02/2014
3	Messenger RNA (mRNA)IBA 01/2021 - 09/2012
3	CollagenIBA 01/2021 - 09/2012
3	hexarelinIBA 11/2019 - 04/2010
3	oxidized low density lipoproteinIBA 11/2019 - 04/2007
3	Growth Hormone (Somatotropin)IBA 11/2019 - 10/2005
3	Apolipoproteins E (ApoE)IBA 11/2019 - 04/2007
3	CalciumIBA 01/2019 - 04/2010
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2019 - 01/2011
3	Glutamic Acid (Glutamate)FDA Link 05/2015 - 10/2012
3	NAD (NADH)IBA 10/2014 - 01/2014
3	ElementsIBA 03/2014 - 01/2014
3	Peptides (Polypeptides)IBA 04/2010 - 10/2005
2	Biological ProductsIBA 01/2022 - 09/2014
2	Adrenergic Agents (Adrenergic Drugs)IBA 11/2019 - 12/2013
2	SecretagoguesIBA 11/2019 - 10/2005
2	Histones (Histone)IBA 02/2014 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 02/2014 - 01/2014
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2014 - 01/2014
2	Carbon Nanotubes (Carbon Nanotube)IBA 01/2014 - 07/2009
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 04/2013 - 10/2012
2	N-Methylaspartate (NMDA)IBA 04/2013 - 10/2012
2	LipidsIBA 04/2012 - 04/2010
2	GhrelinIBA 04/2010 - 01/2006
2	Mitogen-Activated Protein Kinase 3IBA 12/2008 - 10/2008
2	Kv Channel-Interacting Proteins (Calsenilin)IBA 12/2008 - 10/2008
1	Gonadal HormonesIBA 08/2022
1	EnzymesIBA 08/2022
1	SteroidsIBA 08/2022
1	VaccinesIBA 04/2022
1	NLR ProteinsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interferon Type IIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 11/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2021
1	IntegrinsIBA 01/2021
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Actins (F Actin)IBA 01/2020
1	Calcium Release Activated Calcium ChannelsIBA 01/2020
1	cadherin 5IBA 01/2020
1	6-methylprednisolone-21-hemisuberate N,N,N'-triethylenediamine amideIBA 01/2020
1	hydrogen sulfite (bisulfite)IBA 11/2019
1	DesminIBA 11/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2019
1	PlatinumIBA 01/2019
1	Kir2.1 channelIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 08/2018
1	tanshinone II A sodium sulfonateIBA 01/2018

Therapy/Procedure

2	Therapeutics 07/2017 - 11/2016
2	Intravenous Infusions 01/2014 - 10/2012
1	Precision Medicine 01/2021
1	Drug Therapy (Chemotherapy) 01/2019